Recurrent Mantle Cell Lymphoma Clinical Trials in Chicago
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +8 more
- Ibrutinib
- +2 more
- Chicago, Illinois
- +2 more
2022-04-05
Apr 5, 2022N
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
- Chicago, Illinois
- +2 more
2021-08-30
Aug 30, 2021U
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +63 more
- therapeutic allogeneic lymphocytes
- laboratory biomarker analysis
- Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
2019-07-17
Jul 17, 2019N
Completed
- Recurrent Mantle Cell Lymphoma
- Bortezomib
- +2 more
- Anaheim, California
- +81 more
2018-10-02
Oct 2, 2018N
Completed
- Recurrent Mantle Cell Lymphoma
- Recurrent Non-Hodgkin Lymphoma
- Bortezomib
- +2 more
- Tampa, Florida
- +11 more
2018-07-11
Jul 11, 2018M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
- Birmingham, Alabama
- +19 more
2016-01-07
Jan 7, 2016N
Completed
- Anaplastic Large Cell Lymphoma
- +5 more
- Chicago, Illinois
- +1 more
2014-05-07
May 7, 2014N
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
- Birmingham, Alabama
- +24 more
2014-04-28
Apr 28, 2014N
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
- Los Angeles, California
- +10 more
2014-03-14
Mar 14, 2014N
Completed
- Recurrent Adult Diffuse Large Cell Lymphoma
- +2 more
- oblimersen sodium
- +7 more
- Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
2013-01-23
Jan 23, 2013N
Completed
- AIDS-related Peripheral/Systemic Lymphoma
- +54 more
- Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
2013-01-23
Jan 23, 2013N
Completed
- AIDS-related Peripheral/Systemic Lymphoma
- +58 more
- irinotecan hydrochloride
- Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
2013-01-23
Jan 23, 2013N
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +44 more
- sorafenib tosylate
- pharmacological study
- Chicago, IllinoisCancer and Leukemia Group B (CALGB) Research Base
2013-01-04
Jan 4, 2013